Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1981 Jul;78(7):4639–4643. doi: 10.1073/pnas.78.7.4639

Anatoxin-a interactions with cholinergic synaptic molecules.

R S Aronstam, B Witkop
PMCID: PMC319849  PMID: 6270690

Abstract

Anatoxin-a, a bicyclic amine isolated from blue-green alga, binds to the nicotinic acetylcholine receptor of Torpedo electric tissue, thereby inducing conformational changes in the postsynaptic receptor--ion channel complex as evidenced by alterations in the binding of radiolabeled ligands to the complex. Anatoxin-a binds to the acetylcholine recognition site (Kd = 0.1--0.2 microM) as indicated by its competitive inhibition of specific [3H]acetylcholine and d-[3H]tubocurarine binding, Anatoxin-a stimulates the binding of three physiologically identified "ion channel blockers," [3H]perhydrohistrionicotoxin, [3H]phencyclidine, and [3H]phencyclidine methiodide. The 50% effective doses for these effects range from 0.14 to 0.28 microM. Incubation of Torpedo membranes with anatoxin-a before addition of a radiolabeled channel probe produces a time- and concentration-dependent attenuation of the binding compared to the situation in which anatoxin-a and the probe are added simultaneously. The time course for the elaboration of this decrease corresponds to electrophysiological measurements of anatoxin-a-induced desensitization of neuromuscular junction responses. In these nicotinic actions, anatoxin-a is about as potent as acetylcholine. Anatoxin-a has relatively low affinity for the muscarinic acetylcholine receptors of rat brain, inhibiting 3-[3H]quinuclidinyl benzilate binding (10(-10) M) by 50% at concentrations between 10 and 20 microM. In contrast to classical muscarinic agonists, anatoxin-a displays little regional selectivity in its binding, and its receptor affinity is unaltered by alkylation of the neural membranes with N-ethylmaleimide.

Full text

PDF
4639

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aronstam R. S., Abood L. G., Hoss W. Influence of sulfhydryl reagents and heavy metals on the functional state of the muscarinic acetylcholine receptor in rat brain. Mol Pharmacol. 1978 Jul;14(4):575–586. [PubMed] [Google Scholar]
  2. Aronstam R. S., Hoss W., Abood L. G. Conversion between configurational states of the muscarinic receptor in rat brain. Eur J Pharmacol. 1977 Dec 1;46(3):279–282. doi: 10.1016/0014-2999(77)90344-2. [DOI] [PubMed] [Google Scholar]
  3. Aronstam R. S., Kellogg C., Abood L. G. Development of muscarinic cholinergic receptors in inbred strains of mice: identification of receptor heterogeneity and relation to audiogenic seizure susceptibility. Brain Res. 1979 Feb 23;162(2):231–241. doi: 10.1016/0006-8993(79)90286-5. [DOI] [PubMed] [Google Scholar]
  4. Aronstam R. S., Triggle D. J., Eldefrawi M. E. Structural and stereochemical requirements for muscarinic receptor binding. Mol Pharmacol. 1979 Mar;15(2):227–234. [PubMed] [Google Scholar]
  5. Birdsall N. J., Burgen A. S., Hulme E. C. The binding of agonists to brain muscarinic receptors. Mol Pharmacol. 1978 Sep;14(5):723–736. [PubMed] [Google Scholar]
  6. Carmichael W. W., Biggs D. F., Gorham P. R. Toxicology and pharmacological action of anabaena flos-aquae toxin. Science. 1975 Feb 14;187(4176):542–544. doi: 10.1126/science.803708. [DOI] [PubMed] [Google Scholar]
  7. Carmichael W. W., Biggs D. F., Peterson M. A. Pharmacology of anatoxin-a, produced by the freshwater cyanophyte Anabaena flos-aquae NRC-44-1. Toxicon. 1979;17(3):229–236. doi: 10.1016/0041-0101(79)90212-5. [DOI] [PubMed] [Google Scholar]
  8. Eldefrawi M. E., Aronstam R. S., Bakry N. M., Eldefrawi A. T., Albuquerque E. X. Activation, inactivation, and desensitization of acetylcholine receptor channel complex detected by binding of perhydrohistrionicotoxin. Proc Natl Acad Sci U S A. 1980 Apr;77(4):2309–2313. doi: 10.1073/pnas.77.4.2309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Elliott J., Raftery M. A. Binding of perhydrohistrionicotoxin to intact and detergent-solubilized membranes enriched in nicotinic acetylcholine receptor. Biochemistry. 1979 May 15;18(10):1868–1874. doi: 10.1021/bi00577a004. [DOI] [PubMed] [Google Scholar]
  10. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  11. Spivak C. E., Witkop B., Albuquerque E. X. Anatoxin-a: a novel, potent agonist at the nicotinic receptor. Mol Pharmacol. 1980 Nov;18(3):384–394. [PubMed] [Google Scholar]
  12. Tsai M. C., Mansour N. A., Eldefrawi A. T., Eldefrawi M. E., Albuquerque E. X. Mechanism of action of amantadine on neuromuscular transmission. Mol Pharmacol. 1978 Sep;14(5):787–803. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES